Prof Greenhalgh

🎄 Happy Holidays from the #CX2024 Team! 🎄 Wishing you all a happy holiday period and looking forward to welcoming the global vascular and endovascular community to London in 2024!

CX Aortic Live: Building the Aortic and Cardiac Community - LIVE Broadcast 📣 On Thursday 14 December, join #CXAortic Live course directors @mraungoo and Tilo Koelbel for an exciting look at what is to come in October including aortic live case presentation, edited cases & more!

🆕 New to #CX2024 - #Carotid & #Peripheral workshops! Thanks to our move to @ExCeLLondon, CX will be hosting new workshops in addition to the #VascularAccess, #Aortic, and #DeepVenous ➡️ View all hands-on activities: cxsymposium.com/cx-2024-worksh…

Professor Roger Greenhalgh, 82: Top vascular surgeon put on standby for presidential visit thetimes.co.uk/article/b00714…

Via ⁦@thetimes⁩ ⁦⁦⁦@ProfGreenhalgh⁩ obit: Top vascular surgeon put on standby for presidential visit thetimes.co.uk/article/b00714…

Today ⁦@ProfGreenhalgh’s obituary appears in @TheLancet. He was lead author in ⁦this prestigious medical journal in 1971 on serum lipids + lipoproteins in arterial disease. He last published in 2016 with the 15-year follow up of the EVAR trials. thelancet.com/journals/lance…

Thank you ⁦@VEITHsymposium⁩ for the tribute lecture + the memories. Here ⁦@ProfGreenhalgh⁩ is as cheeky as ever with Dr Veith. #VascularLegends

Dr Veith memorialized and paid tribute to a great leader and educator in Vascular Surgery... RIP @VascularNews

Just cleared my father’s office at #CharingCross Hospital. Here is a picture of the Drewe lecture theatre where his ⁦@CXSymposium⁩ began in 1978 which has grown from 100s to 4000+ from 80+ countries pre #Covid19. We’ll get there again with our bold move to ⁦@EXCEL⁩.

#LIFE BTK positive results at 1 year will be discussed extensively at #CX2024 as well as latest data from the #Motiv stent - another bioresorbable drug eluting scaffold. #CXVascular ⁦@VascularNews⁩ ⁦@IN_publishing⁩

#CX2024 kicks off with the final resolution of the #Paclitaxel controversy with latest updates from the regulators. Then there is a comparison of the relative safety + efficacy of #Limus vs #Paclitaxel in the fempop segment. #CXVascular ⁦@VascularNews⁩

In Memoriam: ⁦@ProfGreenhalgh⁩. I am delighted that ⁦@imperialcollege⁩ have adapted the obituary first published in ⁦⁦@VascularNews⁩ 👇 imperial.ac.uk/news/249013/in…

Last night was the first #CXvascular LIVE broadcast with a preview of the ⁦@CXSymposium⁩ preliminary programme. In the #CX studio was #CX Co-chair Dittmar Böckler + ⁦@UkVenous⁩. ⁦@VascularNews⁩

Lovely to see this obituary of ⁦@ProfGreenhalgh⁩ appear in “Gefäßchirurgie” today. #RIP ⁦@VascularNews⁩ ⁦@CXSymposium⁩

The funeral of my father, ⁦@ProfGreenhalgh, is later this week. The words that Timothy ascribed to Paul, as he approached death, spring to mind: “I have fought the good fight, I have finished the race, I have kept the faith….”

My father @ProfGreenhalgh’s obituary in @VascularNews. He had a wonderful life. vascularnews.com/obituary-roger…

Lovely to listen to @ProfGreenhalgh’s storytelling in this podcast. Coincidentally, @TelegraphObits have printed his obituary today. I’ll be buying more than one @Telegraph copy which should distract me from the front page by-election news. podcasts.apple.com/gb/podcast/mas…

My father’s obituary in ⁦@Telegraph⁩. RIP dad. telegraph.co.uk/obituaries/202…

Professor Roger M. Greenhalgh, MD, 1941–2023 on @EVToday evtoday.com/news/professor…

My father @ProfGreenhalgh was the chief assistant to #Prof Gerry Taylor at Bart’s in the early 70s. He had some great years working there whilst honing his surgical skills. 👇